CBIZ Inc (CBZ) Stock Analysis
Verdict: WATCH (do not buy)
Price is now capped by the $55.00 Grant Thornton acquisition offer; any further gain is unlikely without a superior counter-bid.
Investment score: 42/100
Analysis as of
Is CBIZ Inc stock worth reviewing? AI model thesis
CBIZ has reached its terminal value for this cycle following the $5B Grant Thornton deal announcement. At $55.25, the stock is overextended relative to the $55.00 transaction price.
7-factor investment score
- Valuation: 10/100 (weight 20%)
- Financial Health: 45/100 (weight 15%)
- Technical Momentum: 50/100 (weight 15%)
- Earnings Quality: 85/100 (weight 15%)
- Insider Sentiment: 50/100 (weight 10%)
- Analyst Consensus: 30/100 (weight 10%)
- Risk-Adjusted Return: 35/100 (weight 15%)
CBIZ Inc opportunities and risks
What speaks for CBZ
- Scale Leadership
What speaks against CBZ
- Price Capped by M&A Terms
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| CBZ | 26.6x | 1.1x | 7.4x | 12.2% | 4.4% | 9.6% |
| PSN | 29.4x | 0.7x | 15.2x | 21.5% | 2.5% | 6.7% |
| KBR | 10.4x | 0.6x | 11.3x | 14.5% | 5.5% | 8.0% |
| AMTM | 36.2x | 0.4x | 9.2x | 7.9% | 1.0% | 8.5% |
| EXPO | 39.4x | 10.6x | 26.5x | 24.6% | 27.9% | 3.6% |
| HURN | 24.0x | 1.4x | 14.7x | 30.5% | 6.4% | 6.2% |
| Peer median | 29.4x | 0.7x | 14.7x | 21.5% | 5.5% | 6.7% |
Frequently asked questions about CBIZ Inc (CBZ)
Is CBZ stock a good investment?
The cached TradeMates AI model rates CBIZ Inc as WATCH (do not buy) with an investment score of 42/100. CBIZ has reached its terminal value for this cycle following the $5B Grant Thornton deal announcement. At $55.25, the stock is overextended relative to the $55.00 transaction price. This is algorithmic model output, not personal investment advice.
Is CBZ stock a buy?
The TradeMates model verdict for CBZ is WATCH (do not buy) with an investment score of 42/100. Treat this as a model signal to review, not a personal buy recommendation.